| Year |
Citation |
Score |
| 2024 |
Ramachandran R, Ibragimova S, Woods LM, AlHouqani T, Gomez RL, Simeoni F, Hachim MY, Somervaille TCP, Philpott A, Carroll JS, Ali FR. Conserved role of FOXC1 in TNBC is parallel to FOXA1 in ER+ breast cancer. Iscience. 27: 110500. PMID 39171293 DOI: 10.1016/j.isci.2024.110500 |
0.471 |
|
| 2024 |
Li Z, Chen F, Chen L, Liu J, Tseng D, Hadi F, Omarjee S, Kishore K, Kent J, Kirkpatrick J, D'Santos C, Lawson M, Gertz J, Sikora MJ, McDonnell DP, ... Carroll JS, et al. EstroGene2.0: A multi-omic database of response to estrogens, ER-modulators, and resistance to endocrine therapies in breast cancer. Biorxiv : the Preprint Server For Biology. PMID 39005294 DOI: 10.1101/2024.06.28.601163 |
0.405 |
|
| 2024 |
Hosseinzadeh L, Kikhtyak Z, Laven-Law G, Pederson SM, Puiu CG, D'Santos CS, Lim E, Carroll JS, Tilley WD, Dwyer AR, Hickey TE. The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer. Genome Biology. 25: 44. PMID 38317241 DOI: 10.1186/s13059-023-03161-y |
0.453 |
|
| 2023 |
Overman J, Fontaine F, Moustaqil M, Mittal D, Sierecki E, Sacilotto N, Zuegg J, Robertson AAB, Holmes K, Salim AA, Mamidyala S, Butler MS, Robinson AS, Lesieur E, Johnston W, ... ... Carroll JS, et al. Correction: Pharmacological targeting of the transcription factor SOX18 delays breast cancer in mice. Elife. 12. PMID 37551662 DOI: 10.7554/eLife.90408 |
0.356 |
|
| 2023 |
Li Z, Li T, Yates ME, Wu Y, Ferber A, Chen L, Brown DD, Carroll JS, Sikora MJ, Tseng GC, Oesterreich S, Lee AV. The EstroGene database reveals diverse temporal, context-dependent, and bidirectional estrogen receptor regulomes in breast cancer. Cancer Research. PMID 37272757 DOI: 10.1158/0008-5472.CAN-23-0539 |
0.419 |
|
| 2023 |
Wu Y, Li Z, Wedn AM, Casey AN, Brown D, Rao SV, Omarjee S, Hooda J, Carroll JS, Gertz J, Atkinson JM, Lee AV, Oesterreich S. FOXA1 reprogramming dictates retinoid X receptor response in ESR1 mutant breast cancer. Molecular Cancer Research : McR. PMID 36930833 DOI: 10.1158/1541-7786.MCR-22-0516 |
0.447 |
|
| 2023 |
Li Z, Li T, Yates ME, Wu Y, Ferber A, Chen L, Brown DD, Carroll JS, Sikora MJ, Tseng GC, Oesterreich S, Lee AV. EstroGene database reveals diverse temporal, context-dependent and directional estrogen receptor regulomes in breast cancer. Biorxiv : the Preprint Server For Biology. PMID 36778377 DOI: 10.1101/2023.01.30.526388 |
0.431 |
|
| 2022 |
Alizadeh-Ghodsi M, Owen KL, Townley SL, Zanker D, Rollin SPG, Hanson AR, Shrestha R, Toubia J, Gargett T, Chernukhin I, Luu J, Cowley KJ, Clark A, Carroll JS, Simpson KJ, et al. Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate Cancer. Cancer Research Communications. 2: 706-724. PMID 36923279 DOI: 10.1158/2767-9764.CRC-21-0139 |
0.305 |
|
| 2022 |
Parkinson LM, Gillen SL, Woods LM, Chaytor L, Marcos D, Ali FR, Carroll JS, Philpott A. The proneural transcription factor ASCL1 regulates cell proliferation and primes for differentiation in neuroblastoma. Frontiers in Cell and Developmental Biology. 10: 942579. PMID 36263020 DOI: 10.3389/fcell.2022.942579 |
0.323 |
|
| 2022 |
Bahl S, Carroll JS, Lupien M. Chromatin Variants Reveal the Genetic Determinants of Oncogenesis in Breast Cancer. Cold Spring Harbor Perspectives in Medicine. PMID 36041880 DOI: 10.1101/cshperspect.a041322 |
0.612 |
|
| 2022 |
Aspros KGM, Carter JM, Hoskin TL, Suman VJ, Subramaniam M, Emch MJ, Ye Z, Sun Z, Sinnwell JP, Thompson KJ, Tang X, Rodman EPB, Wang X, Nelson AW, Chernukhin I, ... ... Carroll JS, et al. Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer. Npj Breast Cancer. 8: 20. PMID 35177654 DOI: 10.1038/s41523-022-00387-0 |
0.408 |
|
| 2022 |
Li Z, Wu Y, Yates ME, Tasdemir N, Bahreini A, Chen J, Levine KM, Priedigkeit NM, Nasrazadani A, Ali S, Buluwela L, Arnesen S, Gertz J, Richer JK, Troness B, ... ... Carroll JS, et al. Hotspot ESR1 mutations are multimodal and contextual modulators of breast cancer metastasis. Cancer Research. PMID 35078818 DOI: 10.1158/0008-5472.CAN-21-2576 |
0.403 |
|
| 2021 |
Che M, Chaturvedi A, Munro SA, Pitzen SP, Ling A, Zhang W, Mentzer J, Ku SY, Puca L, Zhu Y, Bergman AM, Severson TM, Forster C, Liu Y, Hildebrand J, ... ... Carroll JS, et al. Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer. Nature Communications. 12: 6377. PMID 34737261 DOI: 10.1038/s41467-021-26612-1 |
0.314 |
|
| 2021 |
Broome R, Chernukhin I, Jamieson S, Kishore K, Papachristou EK, Mao SQ, Tejedo CG, Mahtey A, Theodorou V, Groen AJ, D'Santos C, Balasubramanian S, Farcas AM, Siersbæk R, Carroll JS. TET2 is a component of the estrogen receptor complex and controls 5mC to 5hmC conversion at estrogen receptor cis-regulatory regions. Cell Reports. 34: 108776. PMID 33626359 DOI: 10.1016/j.celrep.2021.108776 |
0.437 |
|
| 2021 |
Holliday H, Roden D, Junankar S, Wu SZ, Baker LA, Krisp C, Chan CL, McFarland A, Skhinas JN, Cox TR, Pal B, Huntington ND, Ormandy CJ, Carroll JS, Visvader J, et al. Inhibitor of Differentiation 4 (ID4) represses mammary myoepithelial differentiation via inhibition of HEB. Iscience. 24: 102072. PMID 33554073 DOI: 10.1016/j.isci.2021.102072 |
0.318 |
|
| 2021 |
Hickey TE, Selth LA, Chia KM, Laven-Law G, Milioli HH, Roden D, Jindal S, Hui M, Finlay-Schultz J, Ebrahimie E, Birrell SN, Stelloo S, Iggo R, Alexandrou S, Caldon CE, ... ... Carroll JS, et al. The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer. Nature Medicine. PMID 33462444 DOI: 10.1038/s41591-020-01168-7 |
0.434 |
|
| 2021 |
Varešlija D, Ward E, Purcell SP, Cosgrove NS, Cocchiglia S, O'Halloran PJ, Charmsaz S, Bane FT, Brett FM, Farrell M, Cryan J, Beausang A, Hudson L, Turnbul AK, Dixon JM, ... ... Carroll JS, et al. Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotype. Oncogene. PMID 33420368 DOI: 10.1038/s41388-020-01606-3 |
0.477 |
|
| 2020 |
Farcas AM, Nagarajan S, Cosulich S, Carroll JS. Genome-wide estrogen receptor activity in breast cancer. Endocrinology. PMID 33284960 DOI: 10.1210/endocr/bqaa224 |
0.46 |
|
| 2020 |
Giannoudis A, Malki MI, Rudraraju B, Mohhamed H, Menon S, Liloglou T, Ali S, Carroll JS, Palmieri C. Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer. Breast Cancer Research : Bcr. 22: 126. PMID 33198803 DOI: 10.1186/s13058-020-01359-7 |
0.449 |
|
| 2020 |
Ali FR, Marcos D, Chernukhin I, Woods LM, Parkinson LM, Wylie LA, Papkovskaia TD, Davies JD, Carroll JS, Philpott A. Dephosphorylation of the proneural transcription factor ASCL1 re-engages a latent post-mitotic differentiation programme in neuroblastoma. Molecular Cancer Research : McR. PMID 33046535 DOI: 10.1158/1541-7786.MCR-20-0693 |
0.303 |
|
| 2020 |
Wang S, Somisetty VS, Bai B, Chernukhin I, Niskanen H, Kaikkonen MU, Bellet M, Carroll JS, Hurtado A. The proapoptotic gene interferon regulatory factor-1 mediates the antiproliferative outcome of paired box 2 gene and tamoxifen. Oncogene. PMID 32843722 DOI: 10.1038/s41388-020-01435-4 |
0.443 |
|
| 2020 |
Siersbæk R, Scabia V, Nagarajan S, Chernukhin I, Papachristou EK, Broome R, Johnston SJ, Joosten SEP, Green AR, Kumar S, Jones J, Omarjee S, Alvarez-Fernandez R, Glont S, Aitken SJ, ... ... Carroll JS, et al. IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer Metastasis. Cancer Cell. PMID 32679107 DOI: 10.1016/j.ccell.2020.06.007 |
0.345 |
|
| 2020 |
Hruschka N, Kalisz M, Subijana M, Graña-Castro O, Del Cano-Ochoa F, Brunet LP, Chernukhin I, Sagrera A, De Reynies A, Kloesch B, Chin SF, Burgués O, Andreu D, Bermejo B, Cejalvo JM, ... ... Carroll JS, et al. The GATA3 X308_Splice breast cancer mutation is a hormone context-dependent oncogenic driver. Oncogene. PMID 32587399 DOI: 10.1038/S41388-020-1376-3 |
0.406 |
|
| 2020 |
Baker LA, Holliday H, Roden D, Krisp C, Wu SZ, Junankar S, Serandour AA, Mohammed H, Nair R, Sankaranarayanan G, Law AMK, McFarland A, Simpson PT, Lakhani S, Dodson E, ... ... Carroll JS, et al. Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer. Breast Cancer Research : Bcr. 22: 63. PMID 32527287 DOI: 10.1186/S13058-020-01306-6 |
0.389 |
|
| 2020 |
Shu S, Wu HJ, Ge JY, Zeid R, Harris IS, Jovanović B, Murphy K, Wang B, Qiu X, Endress JE, Reyes J, Lim K, Font-Tello A, Syamala S, Xiao T, ... ... Carroll JS, et al. Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer. Molecular Cell. PMID 32416067 DOI: 10.1016/J.Molcel.2020.04.027 |
0.544 |
|
| 2020 |
Nagarajan S, Rao SV, Sutton J, Cheeseman D, Dunn S, Papachristou EK, Prada JG, Couturier DL, Kumar S, Kishore K, Chilamakuri CSR, Glont SE, Goode EA, Brodie C, Guppy N, ... ... Carroll JS, et al. Author Correction: ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response. Nature Genetics. PMID 32005967 DOI: 10.1038/S41588-020-0582-9 |
0.308 |
|
| 2020 |
Nagarajan S, Rao SV, Sutton J, Cheeseman D, Dunn S, Papachristou EK, Prada JG, Couturier DL, Kumar S, Kishore K, Chilamakuri CSR, Glont SE, Archer Goode E, Brodie C, Guppy N, ... ... Carroll JS, et al. ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response. Nature Genetics. PMID 31913353 DOI: 10.1038/S41588-019-0541-5 |
0.421 |
|
| 2020 |
Fachal L, Aschard H, Beesley J, Barnes DR, Allen J, Kar S, Pooley KA, Dennis J, Michailidou K, Turman C, Soucy P, Lemaçon A, Lush M, Tyrer JP, Ghoussaini M, ... ... Carroll JS, et al. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes. Nature Genetics. PMID 31911677 DOI: 10.1038/s41588-019-0537-1 |
0.36 |
|
| 2020 |
Piggin CL, Roden DL, Law AMK, Molloy MP, Krisp C, Swarbrick A, Naylor MJ, Kalyuga M, Kaplan W, Oakes SR, Gallego-Ortega D, Clark SJ, Carroll JS, Bartonicek N, Ormandy CJ. ELF5 modulates the estrogen receptor cistrome in breast cancer. Plos Genetics. 16: e1008531. PMID 31895944 DOI: 10.1371/journal.pgen.1008531 |
0.434 |
|
| 2020 |
Zeng YA, Carroll J, Borniger J. Decision letter: Three-dimensional growth of breast cancer cells potentiates the anti-tumor effects of unacylated ghrelin and AZP-531 Elife. DOI: 10.7554/Elife.56913.Sa1 |
0.399 |
|
| 2020 |
Hickey TE, Selth L, Chia KM, Milioli H, Roden D, Laven-Law G, Jindal S, Hui M, Ebrahimie E, birrell S, Stelloo S, Caldon E, Findlay-Schultz J, Abdel_Fatah T, Ellis I, ... ... Carroll JS, et al. OR05-06 The Androgen Receptor Is a Tumour Suppressor in Estrogen Receptor Positive Breast Cancer Journal of the Endocrine Society. 4. DOI: 10.1210/jendso/bvaa046.982 |
0.46 |
|
| 2020 |
Li Z, Levine KM, Arneson S, Berrett KC, Priedigkeit NM, Bahreini A, Chen J, Zhu L, Carroll JS, Tseng GC, Lucas PC, Atkinson JM, Gertz J, Lee AV, Oesterreich S. Abstract 4917: Estrogen receptor D538G mutation promotes cell migration via hyperactivation of Wnt signaling pathway Cancer Research. 80: 4917-4917. DOI: 10.1158/1538-7445.Am2020-4917 |
0.36 |
|
| 2019 |
Redmond AM, Omarjee S, Chernukhin I, Le Romancer M, Carroll JS. Analysis of HER2 genomic binding in breast cancer cells identifies a global role in direct gene regulation. Plos One. 14: e0225180. PMID 31747426 DOI: 10.1371/journal.pone.0225180 |
0.48 |
|
| 2019 |
Peluffo G, Subedee A, Harper NW, Kingston N, Jovanović B, Flores F, Stevens LE, Beca F, Trinh A, Reddy Chilamakuri CS, Papachristou EK, Murphy K, Su Y, Marusyk A, D'Santos CS, ... ... Carroll JS, et al. EN1 is a transcriptional dependency in triple-negative breast cancer associated with brain metastasis. Cancer Research. PMID 31239270 DOI: 10.1158/0008-5472.Can-18-3264 |
0.455 |
|
| 2019 |
Glont SE, Papachristou EK, Sawle A, Holmes KA, Carroll JS, Siersbaek R. Identification of ChIP-seq and RIME grade antibodies for Estrogen Receptor alpha. Plos One. 14: e0215340. PMID 30970003 DOI: 10.1371/journal.pone.0215340 |
0.345 |
|
| 2019 |
Goodman ML, Trinca GM, Walter KR, Papachristou EK, D'Santos CS, Li T, Liu Q, Lai Z, Chalise P, Madan R, Fan F, Markiewicz MA, Jin VX, Carroll JS, Hagan CR. Progesterone Receptor Attenuates STAT1-Mediated IFN Signaling in Breast Cancer. Journal of Immunology (Baltimore, Md. : 1950). PMID 30936295 DOI: 10.4049/Jimmunol.1801152 |
0.392 |
|
| 2019 |
Glont SE, Chernukhin I, Carroll JS. Comprehensive Genomic Analysis Reveals that the Pioneering Function of FOXA1 Is Independent of Hormonal Signaling. Cell Reports. 26: 2558-2565.e3. PMID 30840881 DOI: 10.1016/j.celrep.2019.02.036 |
0.408 |
|
| 2019 |
Aspros K, Nelson A, Ye Z, Sun Z, Chernukhin I, Carroll J, Ingle J, Goetz M, Hawse J. Abstract P5-05-03: Estrogen receptor beta elicits anti-cancer effects in triple negative breast cancer through suppression of NFκB signaling Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P5-05-03 |
0.556 |
|
| 2019 |
Li Z, Bahreini A, Levine K, Wang P, Tasdemir N, Montanez M, Sundd P, Wallace C, Watkins S, Chu D, Park B, Hou W, Zhu L, Tseng G, Carroll J, et al. Abstract P2-01-09: ESR1 mutations drive breast cancer metastasis by context-dependent alterations in adhesive and migratory properties Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P2-01-09 |
0.428 |
|
| 2019 |
Kumar S, Benson J, McIntosh S, King P, Dougall G, Kateb A, Vallier A, Jones L, Qian W, Provenzano E, Caldas C, Pantziarka P, Carroll J, Baird R. Abstract OT1-01-07: PIONEER- Pre-operative wIndOw study of letrozole plus PR agonist megestrol acetate versus letrozole aloNE in post-menopausal patients with ER-positive breast cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-Ot1-01-07 |
0.459 |
|
| 2018 |
Debaize L, Jakobczyk H, Avner S, Gaudichon J, Rio AG, Sérandour AA, Dorsheimer L, Chalmel F, Carroll JS, Zörnig M, Rieger MA, Delalande O, Salbert G, Galibert MD, Gandemer V, et al. Interplay between transcription regulators RUNX1 and FUBP1 activates an enhancer of the oncogene c-KIT and amplifies cell proliferation. Nucleic Acids Research. 46: 11214-11228. PMID 30500954 DOI: 10.1093/nar/gky756 |
0.308 |
|
| 2018 |
Reese JM, Bruinsma ES, Nelson AW, Chernukhin I, Carroll JS, Li Y, Subramaniam M, Suman VJ, Negron V, Monroe DG, Ingle JN, Goetz MP, Hawse JR. ERβ-mediated induction of cystatins results in suppression of TGFβ signaling and inhibition of triple-negative breast cancer metastasis. Proceedings of the National Academy of Sciences of the United States of America. PMID 30257941 DOI: 10.1073/Pnas.1807751115 |
0.409 |
|
| 2018 |
Siersbæk R, Kumar S, Carroll JS. Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer. Genes & Development. 32: 1141-1154. PMID 30181360 DOI: 10.1101/gad.316646.118 |
0.375 |
|
| 2018 |
Rouhimoghadam M, Safarian S, Carroll JS, Sheibani N, Bidkhori G. Tamoxifen-Induced Apoptosis of MCF-7 Cells via GPR30/PI3K/MAPKs Interactions: Verification by ODE Modeling and RNA Sequencing. Frontiers in Physiology. 9: 907. PMID 30050469 DOI: 10.3389/Fphys.2018.00907 |
0.446 |
|
| 2018 |
Serandour AA, Mohammed H, Miremadi A, Mulder KW, Carroll JS. TRPS1 regulates oestrogen receptor binding and histone acetylation at enhancers. Oncogene. PMID 29895970 DOI: 10.1038/S41388-018-0312-2 |
0.558 |
|
| 2018 |
Ghoussaini M, Edwards SL, Michailidou K, Nord S, Cowper-Sal Lari R, Desai K, Kar S, Hillman KM, Kaufmann S, Glubb DM, Beesley J, Dennis J, Bolla MK, Wang Q, Dicks E, ... ... Carroll J, et al. Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Nature Communications. 9: 16193. PMID 29633761 DOI: 10.1038/Ncomms16193 |
0.629 |
|
| 2018 |
Michaloglou C, Crafter C, Siersbæk R, Delpuech O, Curwen JO, Carnevalli LS, Staniszewska AD, Polanska UM, Cheraghchi-Bashi A, Lawson M, Chernukhin I, McEwen R, Carroll JS, Cosulich SC. Combined inhibition of mTOR and CDK4/6 is required for optimal blockade of E2F function and long term growth inhibition in estrogen receptor positive breast cancer. Molecular Cancer Therapeutics. PMID 29483206 DOI: 10.1158/1535-7163.MCT-17-0537 |
0.398 |
|
| 2018 |
Browne AL, Charmsaz S, Varešlija D, Fagan A, Cosgrove N, Cocchiglia S, Purcell S, Ward E, Bane F, Hudson L, Hill AD, Carroll JS, Redmond AM, Young LS. Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer. Oncogene. PMID 29367763 DOI: 10.1038/s41388-017-0042-x |
0.415 |
|
| 2018 |
Oelmann E, Michaloglou C, Crafter C, Siersbaek R, Delpuech O, Curven J, Carnevalli L, Staniszweska A, Polanska U, Cheraghchi-Bashi A, Lawson M, Chernukhin I, McEwen R, Carroll J, Cosulich S. Abstract PD4-04: Combined inhibition of mTOR and CDK4/6 is required for optimal blockade of E2F function and long term growth inhibition in estrogen receptor positive breast cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Pd4-04 |
0.411 |
|
| 2018 |
Goodman M, Trinca G, Walter K, Papachristou E, D'Santos C, Li T, Liu Q, Lai Z, Chalise P, Madan R, Jin V, Carroll J, Hagan C. Abstract 1800: Progesterone receptor attenuates STAT1-mediated interferon signaling in breast cancer Cancer Research. 78: 1800-1800. DOI: 10.1158/1538-7445.Am2018-1800 |
0.51 |
|
| 2017 |
Martin LA, Ribas R, Simigdala N, Schuster E, Pancholi S, Tenev T, Gellert P, Buluwela L, Harrod A, Thornhill A, Nikitorowicz-Buniak J, Bhamra A, Turgeon MO, Poulogiannis G, Gao Q, ... ... Carroll J, et al. Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance. Nature Communications. 8: 1865. PMID 29192207 DOI: 10.1038/S41467-017-01864-Y |
0.389 |
|
| 2017 |
Michailidou K, Lindström S, Dennis J, Beesley J, Hui S, Kar S, Lemaçon A, Soucy P, Glubb D, Rostamianfar A, Bolla MK, Wang Q, Tyrer J, Dicks E, Lee A, ... ... Carroll JS, et al. Association analysis identifies 65 new breast cancer risk loci. Nature. PMID 29059683 DOI: 10.1038/Nature24284 |
0.4 |
|
| 2017 |
Chiang IK, Fritzsche M, Pichol-Thievend C, Neal A, Holmes K, Lagendijk A, Overman J, D'Angelo D, Omini A, Hermkens D, Lesieur E, Fossat N, Radziewic T, Liu K, Ratnayaka I, ... ... Carroll J, et al. Correction: SoxF factors induce Notch1 expression via direct transcriptional regulation during early arterial development. Development doi: 10.1242/dev.146241. Development (Cambridge, England). 144: 3847-3848. PMID 29042478 DOI: 10.1242/Dev.159715 |
0.339 |
|
| 2017 |
Chiang IK, Fritzsche M, Pichol-Thievend C, Neal A, Holmes K, Lagendijk A, Overman J, D'Angelo D, Omini A, Hermkens D, Lesieur E, Liu K, Ratnayaka I, Corada M, Bou-Gharios G, ... Carroll J, et al. SoxF factors induce Notch1 expression via direct transcriptional regulation during early arterial development. Development (Cambridge, England). PMID 28619820 DOI: 10.1242/Dev.146241 |
0.411 |
|
| 2017 |
Jeselsohn R, Cornwell M, Pun M, Buchwalter G, Nguyen M, Bango C, Huang Y, Kuang Y, Paweletz C, Fu X, Nardone A, De Angelis C, Detre S, Dodson A, Mohammed H, ... Carroll JS, et al. Embryonic transcription factor SOX9 drives breast cancer endocrine resistance. Proceedings of the National Academy of Sciences of the United States of America. PMID 28507152 DOI: 10.1073/Pnas.1620993114 |
0.739 |
|
| 2017 |
Paltoglou S, Das R, Townley SL, Hickey T, Tarulli G, Coutinho I, Fernandes RC, Hanson A, Denis I, Carroll J, Dehm SM, Raj GV, Plymate S, Tilley WD, Selth LA. Novel androgen receptor co-regulator GRHL2 exerts both oncogenic and anti-metastatic functions in prostate cancer. Cancer Research. PMID 28473532 DOI: 10.1158/0008-5472.Can-16-1616 |
0.322 |
|
| 2017 |
Dubois-Chevalier J, Dubois V, Dehondt H, Mazrooei P, Mazuy C, Sérandour AA, Gheeraert C, Penderia G, Baugé E, Derudas B, Hennuyer N, Paumelle R, Marot G, Carroll JS, Lupien M, et al. The logic of transcriptional regulator recruitment architecture at cis-regulatory modules controlling liver functions. Genome Research. PMID 28400425 DOI: 10.1101/Gr.217075.116 |
0.567 |
|
| 2017 |
Overman J, Fontaine F, Moustaqil M, Mittal D, Sierecki E, Sacilotto N, Zuegg J, Robertson AA, Holmes K, Salim AA, Mamidyala S, Butler MS, Robinson AS, Lesieur E, Johnston W, ... ... Carroll JS, et al. Pharmacological targeting of the transcription factor SOX18 delays breast cancer in mice. Elife. 6. PMID 28137359 DOI: 10.7554/Elife.21221 |
0.338 |
|
| 2017 |
Reese J, Bruinsma E, Suman V, Nelson A, Chernukhin I, Carroll J, Ingle J, Goetz M, Hawse J. Abstract P3-07-20: Biological functions of ERβ in triple negative breast cancer and its utility as a novel therapeutic drug target Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P3-07-20 |
0.43 |
|
| 2017 |
Kumar S, Dougall G, Vallier A, Jones L, Qian W, Provenzano E, Caldas C, Pantziarka P, Carroll J, Baird R. PIONEER- Pre-operative wIndOw study of letrozole plus PR agonist megestrol acetate versus letrozole aloNE in post-menopausal patients with ER-positive breast cancer Annals of Oncology. 28: v65-v66. DOI: 10.1093/ANNONC/MDX362.062 |
0.351 |
|
| 2016 |
Jozwik KM, Chernukhin I, Serandour AA, Nagarajan S, Carroll JS. FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3. Cell Reports. 17: 2715-2723. PMID 27926873 DOI: 10.1016/j.celrep.2016.11.028 |
0.361 |
|
| 2016 |
Nelson AW, Groen AJ, Miller JL, Warren AY, Holmes KA, Tarulli GA, Tilley WD, Katzenellenbogen BS, Hawse JR, Gnanapragasam VJ, Carroll JS. Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity. Molecular and Cellular Endocrinology. PMID 27889472 DOI: 10.1016/J.Mce.2016.11.016 |
0.328 |
|
| 2016 |
Carroll JS, Hickey TE, Tarulli GA, Williams M, Tilley WD. Deciphering the divergent roles of progestogens in breast cancer. Nature Reviews. Cancer. PMID 27885264 DOI: 10.1038/nrc.2016.116 |
0.394 |
|
| 2016 |
Hu DG, Selth L, Tarulli G, Meech R, Chanawong A, Wijayakumara D, Russell R, Caldas C, Robinson JL, Carroll J, Tilley WD, MacKenzie PI, Hickey T. Androgen and estrogen receptors in breast cancer co-regulate human UDP-glucuronosyltransferases 2B15 and 2B17. Cancer Research. PMID 27496708 DOI: 10.1158/0008-5472.CAN-15-3372 |
0.492 |
|
| 2016 |
Carroll JS. Mechanisms of oestrogen receptor (ER) gene regulation in breast cancer. European Journal of Endocrinology / European Federation of Endocrine Societies. 175: R41-9. PMID 26884552 DOI: 10.1530/Eje-16-0124 |
0.555 |
|
| 2016 |
Shu S, Lin CY, He HH, Witwicki RM, Tabassum DP, Roberts JM, Janiszewska M, Jin Huh S, Liang Y, Ryan J, Doherty E, Mohammed H, Guo H, Stover DG, Ekram MB, ... ... Carroll JS, et al. Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer. Nature. PMID 26735014 DOI: 10.1038/Nature16508 |
0.556 |
|
| 2016 |
Holmes KA, Brown GD, Carroll JS. Chromatin Immunoprecipitation-Sequencing (ChIP-seq) for Mapping of Estrogen Receptor-Chromatin Interactions in Breast Cancer. Methods in Molecular Biology (Clifton, N.J.). 1366: 79-98. PMID 26585129 DOI: 10.1007/978-1-4939-3127-9_8 |
0.392 |
|
| 2016 |
Shu S, Lin C, He HH, Witwicki R, Roberts J, Tabassum D, Liang Y, Ekram M, Doherty E, Brown J, Mohammed H, D'Santos C, McKeown M, Ott C, Qi J, ... ... Carroll J, et al. Abstract B16: Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Advbc15-B16 |
0.648 |
|
| 2016 |
Palmieri C, Rudraraju B, Giannoudis A, Moore D, Shaw J, Chan S, Ellis I, Caldas C, Coombes R, Carroll J, Ali S, Abdel-Fatah T. Abstract P5-08-17: A study of c-Jun N-terminal kinase (JNK) and c-Jun as biomarkers in early breast cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P5-08-17 |
0.358 |
|
| 2016 |
Asim M, Massie C, Warren A, Luko K, Chohan B, Menon S, Baridi A, Orafidiya F, Zhao W, Escriu C, Mohammed H, D’Santos C, Yang X, Taylor C, Qureshi A, ... ... Carroll J, et al. Abstract LB-003: Androgen-regulated proteome reveals a therapeutically relevant androgen receptor coactivator target in prostate cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-003 |
0.404 |
|
| 2016 |
Trinca G, Goodman M, Workman L, Carroll J, D’Santos C, Slawson C, Hagan CR. Abstract 1818: Coregulation of progesterone receptor and O-GlcNAc in breast cancer Cancer Research. 76: 1818-1818. DOI: 10.1158/1538-7445.Am2016-1818 |
0.48 |
|
| 2016 |
Carroll J. Understanding estrogen receptor transcription in breast cancer European Journal of Cancer. 61: S9. DOI: 10.1016/S0959-8049(16)61019-5 |
0.445 |
|
| 2015 |
Baird RD, Carroll JS. Understanding Oestrogen Receptor Function in Breast Cancer and its Interaction with the Progesterone Receptor. New Preclinical Findings and their Clinical Implications. Clinical Oncology (Royal College of Radiologists (Great Britain)). PMID 26548499 DOI: 10.1016/j.clon.2015.10.005 |
0.336 |
|
| 2015 |
D'Santos C, Taylor C, Carroll JS, Mohammed H. RIME proteomics of estrogen and progesterone receptors in breast cancer. Data in Brief. 5: 276-80. PMID 26543891 DOI: 10.1016/j.dib.2015.08.019 |
0.433 |
|
| 2015 |
Periyasamy M, Patel H, Lai CF, Nguyen VT, Nevedomskaya E, Harrod A, Russell R, Remenyi J, Ochocka AM, Thomas RS, Fuller-Pace F, Győrffy B, Caldas C, Navaratnam N, Carroll JS, et al. APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer. Cell Reports. 13: 108-21. PMID 26411678 DOI: 10.1016/J.Celrep.2015.08.066 |
0.466 |
|
| 2015 |
Zwart W, Flach KD, Rudraraju B, Abdel-Fatah TM, Gojis O, Moore D, Nevedomskaya E, Opdam M, Droog M, Hofland I, Chan SY, Shaw J, Ellis IO, Coombes RC, Carroll JS, et al. SRC3 phosphorylation at Serine 543 is a positive independent prognostic factor in ER positive breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26369632 DOI: 10.1158/1078-0432.CCR-14-3277 |
0.43 |
|
| 2015 |
Mohammed H, Russell IA, Stark R, Rueda OM, Hickey TE, Tarulli GA, Serandour AA, Birrell SN, Bruna A, Saadi A, Menon S, Hadfield J, Pugh M, Raj GV, Brown GD, ... ... Carroll JS, et al. Corrigendum: Progesterone receptor modulates ERα action in breast cancer. Nature. 526: 144. PMID 26245370 DOI: 10.1038/Nature14959 |
0.338 |
|
| 2015 |
Mohammed H, Russell IA, Stark R, Rueda OM, Hickey TE, Tarulli GA, Serandour AA, Serandour AA, Birrell SN, Bruna A, Saadi A, Menon S, Hadfield J, Pugh M, Raj GV, ... ... Carroll JS, et al. Progesterone receptor modulates ERα action in breast cancer. Nature. 523: 313-7. PMID 26153859 DOI: 10.1038/Nature14583 |
0.461 |
|
| 2015 |
Johnston SJ, Carroll JS. Transcription factors and chromatin proteins as therapeutic targets in cancer. Biochimica Et Biophysica Acta. 1855: 183-192. PMID 25721328 DOI: 10.1016/j.bbcan.2015.02.002 |
0.325 |
|
| 2015 |
Redmond AM, Byrne C, Bane FT, Brown GD, Tibbitts P, O'Brien K, Hill AD, Carroll JS, Young LS. Genomic interaction between ER and HMGB2 identifies DDX18 as a novel driver of endocrine resistance in breast cancer cells. Oncogene. 34: 3871-80. PMID 25284587 DOI: 10.1038/onc.2014.323 |
0.454 |
|
| 2015 |
roffey j, Lejeune A, Barnard M, Stock J, Wong AC, McKelvie J, Holmes K, Carroll J, Myatt S. Abstract LB-125: The identification of FOXA1/ERα pathway modulators for the treatment of hormone-based therapy resistant breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-125 |
0.553 |
|
| 2015 |
McNair C, Goodwin J, Augello M, Urbanucci A, Schiewer M, Comstock C, Ertel A, Wang L, Wang Q, Mills I, Li W, Carroll J, Knudsen K. Abstract 1844: Genome wide analysis of AR-cell cycle interplay reveals novel functions in cancer Cancer Research. 75: 1844-1844. DOI: 10.1158/1538-7445.Am2015-1844 |
0.411 |
|
| 2015 |
Mohammed H, Russell IA, Stark R, Rueda OM, Hickey TE, Tarulli GA, Serandour AAA, Birrell SN, Bruna A, Saadi A, Menon S, Hadfield J, Pugh M, Raj GV, Brown GD, ... ... Carroll JS, et al. Progesterone receptor modulates ERα action in breast cancer Nature. 523: 313-317. DOI: 10.1038/nature14583 |
0.379 |
|
| 2015 |
D'Santos C, Taylor C, Carroll JS, Mohammed H. RIME proteomics of estrogen and progesterone receptors in breast cancer Data in Brief. 5: 276-280. DOI: 10.1016/j.dib.2015.08.019 |
0.396 |
|
| 2014 |
Ghoussaini M, Edwards SL, Michailidou K, Nord S, Cowper-Sal Lari R, Desai K, Kar S, Hillman KM, Kaufmann S, Glubb DM, Beesley J, Dennis J, Bolla MK, Wang Q, Dicks E, ... ... Carroll J, et al. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Nature Communications. 4: 4999. PMID 25248036 DOI: 10.1038/Ncomms5999 |
0.648 |
|
| 2014 |
Rosell M, Nevedomskaya E, Stelloo S, Nautiyal J, Poliandri A, Steel JH, Wessels LF, Carroll JS, Parker MG, Zwart W. Complex formation and function of estrogen receptor α in transcription requires RIP140. Cancer Research. 74: 5469-79. PMID 25145671 DOI: 10.1158/0008-5472.CAN-13-3429 |
0.494 |
|
| 2014 |
Rudraraju B, Droog M, Abdel-Fatah TM, Zwart W, Giannoudis A, Malki MI, Moore D, Patel H, Shaw J, Ellis IO, Chan S, Brooke GN, Nevedomskaya E, Lo Nigro C, Carroll J, et al. Phosphorylation of activating transcription factor-2 (ATF-2) within the activation domain is a key determinant of sensitivity to tamoxifen in breast cancer. Breast Cancer Research and Treatment. 147: 295-309. PMID 25141981 DOI: 10.1007/S10549-014-3098-0 |
0.466 |
|
| 2014 |
Owens TW, Rogers RL, Best SA, Ledger A, Mooney AM, Ferguson A, Shore P, Swarbrick A, Ormandy CJ, Simpson PT, Carroll JS, Visvader JE, Naylor MJ. Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancer. Cancer Research. 74: 5277-86. PMID 25056120 DOI: 10.1158/0008-5472.CAN-14-0053 |
0.422 |
|
| 2014 |
Ji Z, Mohammed H, Webber A, Ridsdale J, Han N, Carroll JS, Sharrocks AD. The forkhead transcription factor FOXK2 acts as a chromatin targeting factor for the BAP1-containing histone deubiquitinase complex. Nucleic Acids Research. 42: 6232-42. PMID 24748658 DOI: 10.1093/Nar/Gku274 |
0.302 |
|
| 2014 |
Robinson JL, Hickey TE, Warren AY, Vowler SL, Carroll T, Lamb AD, Papoutsoglou N, Neal DE, Tilley WD, Carroll JS. Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype. Oncogene. 33: 5666-74. PMID 24292680 DOI: 10.1038/onc.2013.508 |
0.313 |
|
| 2014 |
Carroll JS. Steroids, nuclear receptors and breast cancer. Preface. Molecular and Cellular Endocrinology. 382: 623. PMID 24125839 DOI: 10.1016/j.mce.2013.10.004 |
0.391 |
|
| 2014 |
Redmond A, Carroll J. 410: HER2 binds to the genome at specific regulatory sites of key genes in breast cancer European Journal of Cancer. 50: S98. DOI: 10.1016/S0959-8049(14)50365-6 |
0.408 |
|
| 2014 |
Carroll J. 375: Understanding estrogen receptor transcription in breast cancer European Journal of Cancer. 50: S89. DOI: 10.1016/s0959-8049(14)50334-6 |
0.445 |
|
| 2013 |
Lai CF, Flach KD, Alexi X, Fox SP, Ottaviani S, Thiruchelvam PT, Kyle FJ, Thomas RS, Launchbury R, Hua H, Callaghan HB, Carroll JS, Charles Coombes R, Zwart W, Buluwela L, et al. Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells. Nucleic Acids Research. 41: 10228-40. PMID 24049078 DOI: 10.1093/nar/gkt827 |
0.479 |
|
| 2013 |
Bhat-Nakshatri P, Song EK, Collins NR, Uversky VN, Dunker AK, O'Malley BW, Geistlinger TR, Carroll JS, Brown M, Nakshatri H. Interplay between estrogen receptor and AKT in estradiol-induced alternative splicing. Bmc Medical Genomics. 6: 21. PMID 23758675 DOI: 10.1186/1755-8794-6-21 |
0.495 |
|
| 2013 |
Zwart W, Koornstra R, Wesseling J, Rutgers E, Linn S, Carroll JS. A carrier-assisted ChIP-seq method for estrogen receptor-chromatin interactions from breast cancer core needle biopsy samples. Bmc Genomics. 14: 232. PMID 23565824 DOI: 10.1186/1471-2164-14-232 |
0.466 |
|
| 2013 |
Robinson JL, Holmes KA, Carroll JS. FOXA1 mutations in hormone-dependent cancers. Frontiers in Oncology. 3: 20. PMID 23420418 DOI: 10.3389/fonc.2013.00020 |
0.433 |
|
| 2013 |
Mohammed H, D'Santos C, Serandour AA, Ali HR, Brown GD, Atkins A, Rueda OM, Holmes KA, Theodorou V, Robinson JL, Zwart W, Saadi A, Ross-Innes CS, Chin SF, Menon S, ... ... Carroll JS, et al. Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. Cell Reports. 3: 342-9. PMID 23403292 DOI: 10.1016/j.celrep.2013.01.010 |
0.447 |
|
| 2013 |
Sanders DA, Ross-Innes CS, Beraldi D, Carroll JS, Balasubramanian S. Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells. Genome Biology. 14: R6. PMID 23347430 DOI: 10.1186/Gb-2013-14-1-R6 |
0.516 |
|
| 2013 |
Theodorou V, Stark R, Menon S, Carroll JS. GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility. Genome Research. 23: 12-22. PMID 23172872 DOI: 10.1101/gr.139469.112 |
0.498 |
|
| 2013 |
Carroll JS. Understanding estrogen receptor transcription in breast cancer Clinical Epigenetics. 5. DOI: 10.1186/1868-7083-5-S1-S7 |
0.445 |
|
| 2013 |
Carroll J. Abstract P4-04-01: Understanding estrogen receptor transcription in breast cancer Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P4-04-01 |
0.578 |
|
| 2013 |
Carroll J. Abstract AL-1: AACR outstanding investigator award for breast cancer research: Understanding estrogen receptor transcription in breast cancer Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-Al-1 |
0.571 |
|
| 2012 |
Kalyuga M, Gallego-Ortega D, Lee HJ, Roden DL, Cowley MJ, Caldon CE, Stone A, Allerdice SL, Valdes-Mora F, Launchbury R, Statham AL, Armstrong N, Alles MC, Young A, Egger A, ... ... Carroll JS, et al. ELF5 suppresses estrogen sensitivity and underpins the acquisition of antiestrogen resistance in luminal breast cancer. Plos Biology. 10: e1001461. PMID 23300383 DOI: 10.1371/journal.pbio.1001461 |
0.495 |
|
| 2012 |
Magnani L, Carroll J, Zwart W, Palmieri C. ChIPing away at breast cancer. The Lancet. Oncology. 13: 1185-7. PMID 23182190 DOI: 10.1016/S1470-2045(12)70511-9 |
0.456 |
|
| 2012 |
Meyer KB, Carroll JS. FOXA1 and breast cancer risk. Nature Genetics. 44: 1176-7. PMID 23104063 DOI: 10.1038/ng.2449 |
0.331 |
|
| 2012 |
Hickey TE, Robinson JL, Carroll JS, Tilley WD. Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene? Molecular Endocrinology (Baltimore, Md.). 26: 1252-67. PMID 22745190 DOI: 10.1210/me.2012-1107 |
0.431 |
|
| 2012 |
Robinson JL, Carroll JS. FoxA1 is a key mediator of hormonal response in breast and prostate cancer. Frontiers in Endocrinology. 3: 68. PMID 22649425 DOI: 10.3389/fendo.2012.00068 |
0.441 |
|
| 2012 |
Jozwik KM, Carroll JS. Pioneer factors in hormone-dependent cancers. Nature Reviews. Cancer. 12: 381-5. PMID 22555282 DOI: 10.1038/nrc3263 |
0.39 |
|
| 2012 |
Natrajan R, Mackay A, Lambros MB, Weigelt B, Wilkerson PM, Manie E, Grigoriadis A, A'hern R, van der Groep P, Kozarewa I, Popova T, Mariani O, Turajlic S, Furney SJ, Marais R, ... ... Carroll J, et al. A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancers. The Journal of Pathology. 227: 29-41. PMID 22362584 DOI: 10.1002/Path.4003 |
0.478 |
|
| 2012 |
Ross-Innes CS, Stark R, Teschendorff AE, Holmes KA, Ali HR, Dunning MJ, Brown GD, Gojis O, Ellis IO, Green AR, Ali S, Chin SF, Palmieri C, Caldas C, Carroll JS. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature. 481: 389-93. PMID 22217937 DOI: 10.1038/nature10730 |
0.428 |
|
| 2012 |
Krijgsman O, Roepman P, Zwart W, Carroll JS, Tian S, de Snoo FA, Bender RA, Bernards R, Glas AM. A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response. Breast Cancer Research and Treatment. 133: 37-47. PMID 21814749 DOI: 10.1007/s10549-011-1683-z |
0.388 |
|
| 2012 |
Holmes KA, Hurtado A, Brown GD, Launchbury R, Ross-Innes CS, Hadfield J, Odom DT, Carroll JS. Transducin-like enhancer protein 1 mediates estrogen receptor binding and transcriptional activity in breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 109: 2748-53. PMID 21536917 DOI: 10.1073/Pnas.1018863108 |
0.416 |
|
| 2012 |
Carroll J. Abstract PL-2: Estrogen Receptor Cistrome: Implications for Breast Cancer Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-Pl-2 |
0.564 |
|
| 2012 |
Robinson JLL, MacArthur S, Ross-Innes CS, Tilley WD, Neal DE, Mills IG, Carroll JS. Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1 The Embo Journal. 31: 1617-1617. DOI: 10.1038/emboj.2012.59 |
0.434 |
|
| 2011 |
Zwart W, De Snoo F, Krijgsman O, Roepman P, Tian S, Glas A, Bender RA, Carroll J, Bernards R. Use of a gene profile to identify molecular subtypes of breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 537. PMID 28021484 DOI: 10.1200/Jco.2011.29.15_Suppl.537 |
0.545 |
|
| 2011 |
Ross-Innes CS, Brown GD, Carroll JS. A co-ordinated interaction between CTCF and ER in breast cancer cells. Bmc Genomics. 12: 593. PMID 22142239 DOI: 10.1186/1471-2164-12-593 |
0.449 |
|
| 2011 |
Zaret KS, Carroll JS. Pioneer transcription factors: establishing competence for gene expression. Genes & Development. 25: 2227-41. PMID 22056668 DOI: 10.1101/Gad.176826.111 |
0.307 |
|
| 2011 |
Zwart W, Theodorou V, Kok M, Canisius S, Linn S, Carroll JS. Oestrogen receptor-co-factor-chromatin specificity in the transcriptional regulation of breast cancer. The Embo Journal. 30: 4764-76. PMID 22002538 DOI: 10.1038/emboj.2011.368 |
0.455 |
|
| 2011 |
Meyer KB, Maia AT, O'Reilly M, Ghoussaini M, Prathalingam R, Porter-Gill P, Ambs S, Prokunina-Olsson L, Carroll J, Ponder BAJ. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression Plos Genetics. 7. PMID 21814516 DOI: 10.1371/Journal.Pgen.1002165 |
0.42 |
|
| 2011 |
Robinson JL, Macarthur S, Ross-Innes CS, Tilley WD, Neal DE, Mills IG, Carroll JS. Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1. The Embo Journal. 30: 3019-27. PMID 21701558 DOI: 10.1038/emboj.2011.216 |
0.486 |
|
| 2011 |
Holland DG, Burleigh A, Git A, Goldgraben MA, Perez-Mancera PA, Chin SF, Hurtado A, Bruna A, Ali HR, Greenwood W, Dunning MJ, Samarajiwa S, Menon S, Rueda OM, Lynch AG, ... ... Carroll JS, et al. ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium. Embo Molecular Medicine. 3: 167-80. PMID 21337521 DOI: 10.1002/Emmm.201100122 |
0.429 |
|
| 2011 |
Zwart W, Theodorou V, Carroll JS. Estrogen receptor-positive breast cancer: a multidisciplinary challenge. Wiley Interdisciplinary Reviews. Systems Biology and Medicine. 3: 216-30. PMID 21305704 DOI: 10.1002/wsbm.109 |
0.431 |
|
| 2011 |
Hurtado A, Holmes KA, Ross-Innes CS, Schmidt D, Carroll JS. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nature Genetics. 43: 27-33. PMID 21151129 DOI: 10.1038/ng.730 |
0.487 |
|
| 2011 |
Thiruchelvam PT, Lai CF, Hua H, Thomas RS, Hurtado A, Hudson W, Bayly AR, Kyle FJ, Periyasamy M, Photiou A, Spivey AC, Ortlund EA, Whitby RJ, Carroll JS, Coombes RC, et al. The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells. Breast Cancer Research and Treatment. 127: 385-96. PMID 20607599 DOI: 10.1007/S10549-010-0994-9 |
0.518 |
|
| 2011 |
Zwart W, Theodorou V, Kok M, Canisius S, Linn S, Carroll JS. Oestrogen receptor-co-factor-chromatin specificity in the transcriptional regulation of breast cancer The Embo Journal. 30: 4850-4850. DOI: 10.1038/emboj.2011.414 |
0.455 |
|
| 2010 |
Lupien M, Meyer CA, Bailey ST, Eeckhoute J, Cook J, Westerling T, Zhang X, Carroll JS, Rhodes DR, Liu XS, Brown M. Growth factor stimulation induces a distinct ER(alpha) cistrome underlying breast cancer endocrine resistance. Genes & Development. 24: 2219-27. PMID 20889718 DOI: 10.1101/Gad.1944810 |
0.726 |
|
| 2010 |
Badve S, Collins NR, Bhat-Nakshatri P, Turbin D, Leung S, Thorat M, Dunn SE, Geistlinger TR, Carroll JS, Brown M, Bose S, Teitell MA, Nakshatri H. Subcellular localization of activated AKT in estrogen receptor- and progesterone receptor-expressing breast cancers: potential clinical implications. The American Journal of Pathology. 176: 2139-49. PMID 20228224 DOI: 10.2353/Ajpath.2010.090477 |
0.609 |
|
| 2010 |
Schmidt D, Schwalie PC, Ross-Innes CS, Hurtado A, Brown GD, Carroll JS, Flicek P, Odom DT. A CTCF-independent role for cohesin in tissue-specific transcription. Genome Research. 20: 578-88. PMID 20219941 DOI: 10.1101/Gr.100479.109 |
0.465 |
|
| 2010 |
Theodorou V, Carroll JS. Estrogen receptor action in three dimensions - looping the loop. Breast Cancer Research : Bcr. 12: 303. PMID 20156333 DOI: 10.1186/bcr2470 |
0.391 |
|
| 2010 |
Ross-Innes CS, Stark R, Holmes KA, Schmidt D, Spyrou C, Russell R, Massie CE, Vowler SL, Eldridge M, Carroll JS. Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer. Genes & Development. 24: 171-82. PMID 20080953 DOI: 10.1101/gad.552910 |
0.358 |
|
| 2009 |
Redmond AM, Carroll JS. Defining and targeting transcription factors in cancer. Genome Biology. 10: 311. PMID 19664186 DOI: 10.1186/gb-2009-10-7-311 |
0.323 |
|
| 2009 |
Wang Q, Li W, Zhang Y, Yuan X, Xu K, Yu J, Chen Z, Beroukhim R, Wang H, Lupien M, Wu T, Regan MM, Meyer CA, Carroll JS, Manrai AK, et al. Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell. 138: 245-56. PMID 19632176 DOI: 10.1016/J.Cell.2009.04.056 |
0.679 |
|
| 2009 |
Bhat-Nakshatri P, Wang G, Collins NR, Thomson MJ, Geistlinger TR, Carroll JS, Brown M, Hammond S, Srour EF, Liu Y, Nakshatri H. Estradiol-regulated microRNAs control estradiol response in breast cancer cells. Nucleic Acids Research. 37: 4850-61. PMID 19528081 DOI: 10.1093/Nar/Gkp500 |
0.555 |
|
| 2009 |
Nucera C, Eeckhoute J, Finn S, Carroll JS, Ligon AH, Priolo C, Fadda G, Toner M, Sheils O, Attard M, Pontecorvi A, Nose V, Loda M, Brown M. FOXA1 is a potential oncogene in anaplastic thyroid carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 3680-9. PMID 19470727 DOI: 10.1158/1078-0432.Ccr-08-3155 |
0.419 |
|
| 2009 |
Xia X, Lemieux ME, Li W, Carroll JS, Brown M, Liu XS, Kung AL. Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis. Proceedings of the National Academy of Sciences of the United States of America. 106: 4260-5. PMID 19255431 DOI: 10.1073/Pnas.0810067106 |
0.479 |
|
| 2009 |
Hurtado A, Holmes KA, Geistlinger TR, Hutcheson IR, Nicholson RI, Brown M, Jiang J, Howat WJ, Ali S, Carroll JS. Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen (Nature (2008) 456, (663-666)) Nature. 457: 1168. DOI: 10.1038/Nature07835 |
0.404 |
|
| 2008 |
Hurtado A, Holmes KA, Geistlinger TR, Hutcheson IR, Nicholson RI, Brown M, Jiang J, Howat WJ, Ali S, Carroll JS. Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen. Nature. 456: 663-6. PMID 19005469 DOI: 10.1038/Nature07483 |
0.656 |
|
| 2008 |
Bhat-Nakshatri P, Wang G, Appaiah H, Luktuke N, Carroll JS, Geistlinger TR, Brown M, Badve S, Liu Y, Nakshatri H. AKT alters genome-wide estrogen receptor alpha binding and impacts estrogen signaling in breast cancer. Molecular and Cellular Biology. 28: 7487-503. PMID 18838536 DOI: 10.1128/Mcb.00799-08 |
0.633 |
|
| 2008 |
Krum SA, Miranda-Carboni GA, Lupien M, Eeckhoute J, Carroll JS, Brown M. Unique ERalpha cistromes control cell type-specific gene regulation. Molecular Endocrinology (Baltimore, Md.). 22: 2393-406. PMID 18818283 DOI: 10.1210/Me.2008-0100 |
0.691 |
|
| 2008 |
Holmes KA, Song JS, Liu XS, Brown M, Carroll JS. Nkx3-1 and LEF-1 function as transcriptional inhibitors of estrogen receptor activity. Cancer Research. 68: 7380-5. PMID 18794125 DOI: 10.1158/0008-5472.Can-08-0133 |
0.609 |
|
| 2008 |
Dietz SC, Carroll JS. Interrogating the genome to understand oestrogen-receptor-mediated transcription. Expert Reviews in Molecular Medicine. 10: e10. PMID 18377699 DOI: 10.1017/S1462399408000653 |
0.471 |
|
| 2008 |
Li W, Carroll JS, Brown M, Liu xS. xMAN: extreme MApping of OligoNucleotides. Bmc Genomics. 9: S20. PMID 18366610 DOI: 10.1186/1471-2164-9-S1-S20 |
0.381 |
|
| 2008 |
Lupien M, Eeckhoute J, Meyer CA, Wang Q, Zhang Y, Li W, Carroll JS, Liu XS, Brown M. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell. 132: 958-70. PMID 18358809 DOI: 10.1016/J.Cell.2008.01.018 |
0.649 |
|
| 2008 |
Johnson DS, Li W, Gordon DB, Bhattacharjee A, Curry B, Ghosh J, Brizuela L, Carroll JS, Brown M, Flicek P, Koch CM, Dunham I, Bieda M, Xu X, Farnham PJ, et al. Systematic evaluation of variability in ChIP-chip experiments using predefined DNA targets. Genome Research. 18: 393-403. PMID 18258921 DOI: 10.1101/Gr.7080508 |
0.4 |
|
| 2008 |
Krum SA, Miranda-Carboni GA, Hauschka PV, Carroll JS, Lane TF, Freedman LP, Brown M. Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival. The Embo Journal. 27: 535-45. PMID 18219273 DOI: 10.1038/Sj.Emboj.7601984 |
0.457 |
|
| 2007 |
Green KA, Carroll JS. Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state. Nature Reviews. Cancer. 7: 713-22. PMID 17721435 DOI: 10.1038/nrc2211 |
0.45 |
|
| 2007 |
Wang Q, Li W, Liu XS, Carroll JS, Jänne OA, Keeton EK, Chinnaiyan AM, Pienta KJ, Brown M. A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Molecular Cell. 27: 380-92. PMID 17679089 DOI: 10.1016/J.Molcel.2007.05.041 |
0.545 |
|
| 2007 |
Eeckhoute J, Keeton EK, Lupien M, Krum SA, Carroll JS, Brown M. Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer. Cancer Research. 67: 6477-83. PMID 17616709 DOI: 10.1158/0008-5472.Can-07-0746 |
0.709 |
|
| 2006 |
Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, Brodsky AS, Keeton EK, Fertuck KC, Hall GF, Wang Q, Bekiranov S, Sementchenko V, Fox EA, Silver PA, et al. Genome-wide analysis of estrogen receptor binding sites. Nature Genetics. 38: 1289-97. PMID 17013392 DOI: 10.1038/Ng1901 |
0.645 |
|
| 2006 |
Eeckhoute J, Carroll JS, Geistlinger TR, Torres-Arzayus MI, Brown M. A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer. Genes & Development. 20: 2513-26. PMID 16980581 DOI: 10.1101/Gad.1446006 |
0.657 |
|
| 2006 |
Johnson WE, Li W, Meyer CA, Gottardo R, Carroll JS, Brown M, Liu XS. Model-based analysis of tiling-arrays for ChIP-chip. Proceedings of the National Academy of Sciences of the United States of America. 103: 12457-62. PMID 16895995 DOI: 10.1073/Pnas.0601180103 |
0.398 |
|
| 2006 |
Carroll DK, Carroll JS, Leong CO, Cheng F, Brown M, Mills AA, Brugge JS, Ellisen LW. p63 regulates an adhesion programme and cell survival in epithelial cells. Nature Cell Biology. 8: 551-61. PMID 16715076 DOI: 10.1038/Ncb1420 |
0.466 |
|
| 2006 |
Carroll JS, Brown M. Estrogen receptor target gene: an evolving concept. Molecular Endocrinology (Baltimore, Md.). 20: 1707-14. PMID 16396959 DOI: 10.1210/Me.2005-0334 |
0.595 |
|
| 2005 |
Wang Q, Carroll JS, Brown M. Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Molecular Cell. 19: 631-42. PMID 16137620 DOI: 10.1016/J.Molcel.2005.07.018 |
0.512 |
|
| 2005 |
Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR, Fox EA, Silver PA, Brown M. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell. 122: 33-43. PMID 16009131 DOI: 10.1016/J.Cell.2005.05.008 |
0.769 |
|
| 2003 |
Carroll JS, Lynch DK, Swarbrick A, Renoir JM, Sarcevic B, Daly RJ, Musgrove EA, Sutherland RL. p27(Kip1) induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells. Cancer Research. 63: 4322-6. PMID 12907598 |
0.348 |
|
| 2003 |
Doisneau-Sixou SF, Sergio CM, Carroll JS, Hui R, Musgrove EA, Sutherland RL. Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells. Endocrine-Related Cancer. 10: 179-86. PMID 12790780 DOI: 10.1677/ERC.0.0100179 |
0.349 |
|
| 2003 |
Doisneau-Sixou SF, Cestac P, Chouini S, Carroll JS, Hamilton AD, Sebti SM, Poirot M, Balaguer P, Faye JC, Sutherland RL, Favre G. Contrasting effects of prenyltransferase inhibitors on estrogen-dependent cell cycle progression and estrogen receptor-mediated transcriptional activity in MCF-7 cells. Endocrinology. 144: 989-98. PMID 12586776 DOI: 10.1210/En.2002-220726 |
0.359 |
|
| 2003 |
Sutherland RL, Carroll JS, Sergio CM, Swarbrick A, Musgrove EA. 97. Steroid regulation of breast cancer cell proliferation Reproduction, Fertility and Development. 15: 97. DOI: 10.1071/SRB03Ab97 |
0.426 |
|
| 2002 |
Carroll JS, Swarbrick A, Musgrove EA, Sutherland RL. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens. Cancer Research. 62: 3126-31. PMID 12036924 |
0.359 |
|
| Show low-probability matches. |